Drug intelligence / Profile preview

andrographolide

Development stage
Phase 3
Lead developer
Hutchison Medipharma
Modality
Small Molecules
Administration
Oral, Intravenous, Topical
01

Overview

Andrographolide is a labdane diterpenoid lactone and the principal bioactive compound isolated from the plant Andrographis paniculata. It is widely used in traditional medicine systems such as Traditional Chinese Medicine and Ayurveda for its anti-inflammatory and immunomodulatory properties. Mechanistically, andrographolide exhibits multiple pharmacological effects including inhibition of NF-kappaB activation (a key transcription factor in inflammation), suppression of inducible nitric oxide synthase (iNOS), inhibition of cyclooxygenase 2 (COX‑2), and non‑ATP competitive substrate‑competitive inhibition of glycogen synthase kinase 3 beta (GSK‑3β). It also blocks T-cell proliferation to allogenic stimuli and inhibits chemotactic migration of macrophages. Andrographolide has demonstrated anti-inflammatory[7][9], antiviral[5], antibacterial[5], anticancer[7][9], hepatoprotective[7][9], immunostimulant[4] activities in preclinical studies. Clinical trials have explored its use for ulcerative colitis[4], rheumatoid arthritis[4], multiple sclerosis fatigue reduction[4], upper respiratory tract infections including COVID‑19 adjunct therapy[10]. Its poor water solubility limits oral bioavailability; various formulations are under investigation to improve this property.

Brand names
ANDROGRAPHOLIDE (USP-RS)
Other names
(1R-(1-alpha(E(S)),4abeta,5alpha,6alpha,8aalpha))-3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl)ethylidene)dihydro-4-hydroxy-2(3H)-furanone(3E,4S)-3-(2-((1R,4AS,5R,6R,8AS)-DECAHYDRO-6-HYDROXY-5-(HYDROXYMETHYL)-5,8A-DIMETHYL-2-METHYLENE-1-NAPHTHALENYL)ETHYLIDENE)DIHYDRO-4-HYDROXY-2(3H)-FURANONEANDROGRAPHOLIDE [USP-RS]
02

Targets

NF-κBNOS2 (Nitric Oxide Synthase 2)GSK3 (Glycogen synthase kinase 3 beta)

Beyond the preview

Go deeper on andrographolide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on andrographolide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call